Health Condition 1: C169- Malignant neoplasm of stomach, unspecified
Conditions
Interventions
None listed
Sponsors
Chittaranjan National Cancer Institute
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who will be operated for gastric neoplasm and will be diagnosed with malignant gastric epithelial neoplasms histopathologically. 2. Those who will give informed consent for taking part in the study.
Exclusion criteria
Exclusion criteria: 1. After histopathological diagnosis all benign gastric neoplasms will be excluded. 2. After histopathological diagnosis gastric neoplasms other than malignant gastric epithelial neoplasms will be excluded. 3. Cases where Neoadjuvant chemotherapy have been administered. 4. Those who are not willing to take part in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To study the histopathological and clinicopathological parameters of Gastric Carcinoma in Eastern Indian population. 2. To study the expression of biomarkers ERK1/2 and Bcl-2 in gastric carcinoma patients. 3. To study the correlation between histopathological and clinicopathological parameters with ERK1/2 and Bcl-2 expression in gastric carcinoma patients. Timepoint: 2 Years | — |
Secondary
| Measure | Time frame |
|---|---|
| To establish a correlation between ERK1/2 and Bcl-2 expression in gastric carcinoma if present.Timepoint: 2 Years | — |
Countries
India
Contacts
Public ContactRaya Banerjee
Chittaranjan National Cancer Institute
Outcome results
None listed